2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Neuss, Michael N.; Gilmore, Terry; Belderson, Kristin M.; Billett, Amy L.; Conti-Kalchik, Tara; Harvey, Brittany E.; Hendricks, Carolyn B.; LeFebvre, Kristine B.; Mangu, Pamela B.; McNiff, Kristen; Olsen, MiKaela; Schulmeister, Lisa; Gehr, Ann Von; Polovich, Martha

doi:10.1188/17.onf.31-43

Cited by 88 publications

(87 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, we calculated both LS‐CSF volume and TLS‐CSF volume in pediatric patients for the first time. As LS‐CSF volume is one of the most important factors during spinal anesthesia and TLS‐CSF volume can be used to assess the pharmacokinetics of intrathecal medications, the results from this study will be helpful in understanding these issues of pediatric intrathecal medications.…”

Section: Discussionmentioning

confidence: 99%

Lumbosacral and thoracolumbosacral cerebrospinal fluid volume changes in neonates, infants, children, and adolescents: A retrospective magnetic resonance imaging study

Jang

Lee

Seo

et al. 2018

Pediatric Anesthesia

View full text Add to dashboard Cite

Summary Background The volume of cerebrospinal fluid can affect the pharmacokinetics and pharmacodynamics of local anesthetics for spinal anesthesia and other intrathecal medications. Aims The objective of this study was to estimate the lumbosacral cerebrospinal fluid volume and thoracolumbosacral cerebrospinal fluid volume using magnetic resonance images in pediatric patients from neonates and infants to adolescents. Methods Spinal magnetic resonance images of 500 pediatric patients (age <18 years) were reviewed. The lumbosacral cerebrospinal fluid volumes of 418 patients and thoracolumbosacral cerebrospinal fluid volumes of 248 patients were measured. The relationship between cerebrospinal fluid volumes and age, height, and weight were evaluated. The lumbosacral and thoracolumbosacral cerebrospinal fluid volumes per weight were calculated to elucidate developmental changes. Results The lumbosacral and thoracolumbosacral cerebrospinal fluid volumes showed linear correlations with height (r2 = 0.730 and r2 = 0.661, respectively), whereas they showed curvilinear correlations with age (r2 = 0.752 and r2 = 0.717, respectively) and weight (r2 = 0.734 and r2 = 0.734, respectively). The mean lumbosacral cerebrospinal fluid volume per weight (mL/kg) was 0.85 (standard deviation [SD]: 0.19, 95% confidence interval [CI]: 0.81‐0.90) in neonates and infants, 0.86 (SD: 0.22, 95% CI: 0.83‐0.89) in toddlers and preschoolers, 0.71 (SD: 0.26, 95% CI: 0.66‐0.76) in schoolers, and 0.54 (SD: 0.20, 95% CI: 0.49‐0.60) in adolescents. The mean thoracolumbosacral cerebrospinal fluid volume per weight (mL/kg) was 1.95 (SD: 0.37, 95% CI: 1.86‐2.04) in neonates and infants, 1.82 (SD: 0.41, 95% CI: 1.75‐1.88) in toddlers and preschoolers, 1.38 (SD: 0.40, 95% CI: 1.23‐1.52) in schoolers, and 0.99 (SD: 0.34, 95% CI: 0.45‐1.53) in adolescents. Conclusion The lumbosacral and thoracolumbosacral cerebrospinal fluid volumes in pediatric patients were much smaller than previously presented values, showing linear correlations with height, and demonstrate curvilinear correlations with age and weight.

show abstract

Section: Discussionmentioning

confidence: 99%

Lumbosacral and thoracolumbosacral cerebrospinal fluid volume changes in neonates, infants, children, and adolescents: A retrospective magnetic resonance imaging study

Jang

Lee

Seo

et al. 2018

Pediatric Anesthesia

View full text Add to dashboard Cite

show abstract

“…Guidelines for safe handling of PO chemotherapeutics in human practice have been compiled, attempting to limit potential harms . In veterinary medicine, some environmental contamination also has been documented, and similar precautions should be taken by clients handling veterinary cancer patients undergoing chemotherapy and administering drugs at home to their pets …”

Section: Defining the Problemmentioning

confidence: 99%

ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice

Smith

Klahn

Phillips

et al. 2018

Veterinary Internal Medicne

View full text Add to dashboard Cite

The purpose of this report is to offer a consensus opinion of ACVIM oncology diplomates and technicians on the safe use of cytotoxic chemotherapeutics in veterinary practice. The focus is on minimizing harm to the personnel exposed to the drugs: veterinary practitioners, veterinary technicians, veterinary staff, and pet owners. The safety of the patient receiving these drugs is also of paramount importance, but is not addressed in this statement. Much of the information presented is based on national recommendations by Occupational Safety and Health Administration, National Institute for Occupational Safety and Health, United States Pharmacopeia, and other published regulations. These directives reflect an abundance of caution to minimize exposure to medical personnel, but large‐scale studies about the consequences of long‐term occupational exposure are not available in veterinary medicine. Challenges in the delivery of optimal treatment safely and economically to veterinary patients in general practice without access to a veterinary oncologist or other specialist, because of costs or proximity, remain.

show abstract

“…At stage 4, cancer has normally metastasized to distant sites such as liver, lungs or other organs and tissues. Chemothrapy, in combination with surgery, and targeted therapy are needed [31].…”

Section: The Specificity and Treatment Of Colorectal Cancermentioning

confidence: 99%

Ganoderma lucidum on the inhibition of colorectal cancer

Ye¹,

Jenson²

2017

Hematol Med Oncol

View full text Add to dashboard Cite

Ganoderma lucidum is used in East Asian countries for treatment of a variety of diseases such as hypertension, cardiovascular disease, hepatopathy, chronic hepatitis and many cancers. Accumulating evidence has shown that Ganoderma lucidum has significant benefit for the prevention and treatment of different cancers, particularly colorectal cancer. This review summarizes current Ganoderma lucidum research on colorectal cancer in clinical patient studies, animal model for examination, and molecular mechanistic investigations.

show abstract

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Cited by 88 publications

References 36 publications

Lumbosacral and thoracolumbosacral cerebrospinal fluid volume changes in neonates, infants, children, and adolescents: A retrospective magnetic resonance imaging study

Lumbosacral and thoracolumbosacral cerebrospinal fluid volume changes in neonates, infants, children, and adolescents: A retrospective magnetic resonance imaging study

ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice

Ganoderma lucidum on the inhibition of colorectal cancer

Contact Info

Product

Resources

About